Contact Us
Global Open Angle Glaucoma OAG Market Report 2025

Open-Angle Glaucoma (OAG) Global Market Report 2025 – By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type), By Drug Class (Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Market Size, Trends, And Global Forecast 2025-2034

Open-Angle Glaucoma (OAG) Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Open-Angle Glaucoma (OAG) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Open-Angle Glaucoma (OAG) Market?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions.

The main disease types in open-angle glaucoma (OAG) are open angle glaucoma, angle closure glaucoma, and others. Open-angle glaucoma is a chronic eye condition characterized by increased intraocular pressure leading to gradual optic nerve damage and potential vision loss, often without early symptoms. The drug classes used in the treatment are prostaglandin analogs, beta blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others. The end users include hospitals, homecare, specialty clinics, and others. It is distributed through various channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

Open-Angle Glaucoma (OAG) Market Size and growth rate 2025 to 2029: Graph

What Is The Open-Angle Glaucoma (OAG) Market Size 2025 And Growth Rate?

The open-angle glaucoma (OAG) market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increasing prevalence of glaucoma among aging populations, growing awareness about early detection of eye diseases, rising healthcare expenditure, government initiatives for vision care programs, and expansion of ophthalmology practices globally.

What Is The Open-Angle Glaucoma (OAG) Market Growth Forecast?

The open-angle glaucoma (OAG) market size is expected to see strong growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for combination therapies, rising focus on personalized medicine, improved reimbursement policies for glaucoma treatments, increasing prevalence of lifestyle-induced ocular conditions, and rising demand for non-invasive diagnostic methods. Major trends in the forecast period include growing adoption of AI in glaucoma diagnostics, a shift toward outpatient glaucoma surgical procedures, increasing use of sustained-release glaucoma implants, rising integration of wearable technology for monitoring intraocular pressure, and heightened focus on sustainability in medical device manufacturing.

How Is The Open-Angle Glaucoma (OAG) Market Segmented?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Is Driving The Open-Angle Glaucoma (OAG) Market? Growing Awareness Of Eye Illnesses Drives Growth In The Market

The growing awareness of eye illnesses is expected to propel the growth of the open-angle glaucoma (OAG) market going forward. Eye illnesses encompass medical conditions impacting the structure, function, or vision of the eyes, ranging from minor concerns such as dry eye to serious diseases such as glaucoma and macular degeneration. Their prevalence is rising due to aging populations, prolonged screen exposure, increasing diabetes cases, environmental pollution, and lifestyle habits that strain eye health. Open-angle glaucoma (OAG), a leading cause of blindness, especially among older adults, underscores the critical need for routine eye exams, early diagnosis, and proactive treatment to safeguard against irreversible vision loss. For instance, in October 2023, according to the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, eye care outpatient appointments in the UK exceeded eight million in 2021/22, making it the most in-demand specialty. Additionally, the number of individuals with sight loss, currently surpassing two million, is projected to double to over four million by 2050. Therefore, the growing awareness of eye illnesses is driving growth in the open-angle glaucoma (OAG) market.

Who Are The Major Players In The Global Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

What Are The Key Trends Of The Global Open-Angle Glaucoma (OAG) Market? Innovative Devices Revolutionize Glaucoma Treatment With Minimally Invasive Solutions

Major companies operating in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

What Are Latest Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market? Alcon Inc. Acquires BELKIN Vision Ltd. To Enhance Glaucoma Treatment Portfolio With Innovative DSLT Technology

In July 2024, Alcon Inc., a Switzerland-based ophthalmology company, acquired BELKIN Vision Ltd. for $81 million. This acquisition aims to enhance Alcon's glaucoma portfolio by introducing the direct selective laser trabeculoplasty (DSLT) device, a cutting-edge first-line laser treatment for managing open-angle glaucoma. The move aligns with Alcon's strategy to globally expand access to innovative and minimally invasive glaucoma treatments. BELKIN Vision Ltd. is an Israel-based medical device company providing devices for open-angle glaucoma treatments.

What Is The Regional Outlook For The Global Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the open-angle glaucoma (OAG) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (OAG) market consists of revenues earned by entities by providing services such as optometric services, surgical interventions, medication management, and patient education and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The open-angle glaucoma (OAG) market also includes sales of tonometers, visual field analyzers, and lubricating eye drops. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Open-Angle Glaucoma (OAG) Industry?

The open-angle glaucoma (OAG) market research report is one of a series of new reports from The Business Research Company that provides open-angle glaucoma (OAG) market statistics, including open-angle glaucoma (OAG) industry global market size, regional shares, competitors with open-angle glaucoma (OAG) market share, detailed open-angle glaucoma (OAG) market segments, market trends and opportunities, and any further data you may need to thrive in the open-angle glaucoma (OAG) industry. This open-angle glaucoma (OAG) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Open-Angle Glaucoma (OAG) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 6.55 billion
Revenue Forecast In 2034 $8.42 billion
Growth Rate CAGR of 6.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The open-angle glaucoma (OAG) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Open-Angle Glaucoma (OAG) Market Characteristics

    3. Open-Angle Glaucoma (OAG) Market Trends And Strategies

    4. Open-Angle Glaucoma (OAG) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

    5. Global Open-Angle Glaucoma (OAG) Growth Analysis And Strategic Analysis Framework

    5.1. Global Open-Angle Glaucoma (OAG) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Open-Angle Glaucoma (OAG) Market Growth Rate Analysis

    5.4. Global Open-Angle Glaucoma (OAG) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Open-Angle Glaucoma (OAG) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Open-Angle Glaucoma (OAG) Total Addressable Market (TAM)

    6. Open-Angle Glaucoma (OAG) Market Segmentation

    6.1. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Open Angle Glaucoma

    Angle Closure Glaucoma

    Other Disease Type

    6.2. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Prostaglandin Analog

    Beta Blockers

    Adrenergic Agonist

    Carbonic Anhydrase Inhibitors

    Others Drug Class

    6.3. Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Homecare

    Specialty Clinics

    Other End Users

    6.4. Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospital Pharmacy

    Online Pharmacy

    Retail Pharmacy

    6.5. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Primary Open-Angle Glaucoma (POAG)

    Secondary Open-Angle Glaucoma

    6.6. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Acute Angle-Closure Glaucoma

    Chronic Angle-Closure Glaucoma

    6.7. Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Normal-Tension Glaucoma

    Congenital Glaucoma

    Secondary Glaucoma

    7. Open-Angle Glaucoma (OAG) Market Regional And Country Analysis

    7.1. Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Open-Angle Glaucoma (OAG) Market

    8.1. Asia-Pacific Open-Angle Glaucoma (OAG) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Open-Angle Glaucoma (OAG) Market

    9.1. China Open-Angle Glaucoma (OAG) Market Overview

    9.2. China Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Open-Angle Glaucoma (OAG) Market

    10.1. India Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Open-Angle Glaucoma (OAG) Market

    11.1. Japan Open-Angle Glaucoma (OAG) Market Overview

    11.2. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Open-Angle Glaucoma (OAG) Market

    12.1. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Open-Angle Glaucoma (OAG) Market

    13.1. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Open-Angle Glaucoma (OAG) Market

    14.1. South Korea Open-Angle Glaucoma (OAG) Market Overview

    14.2. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Open-Angle Glaucoma (OAG) Market

    15.1. Western Europe Open-Angle Glaucoma (OAG) Market Overview

    15.2. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Open-Angle Glaucoma (OAG) Market

    16.1. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Open-Angle Glaucoma (OAG) Market

    17.1. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Open-Angle Glaucoma (OAG) Market

    18.1. France Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Open-Angle Glaucoma (OAG) Market

    19.1. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Open-Angle Glaucoma (OAG) Market

    20.1. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Open-Angle Glaucoma (OAG) Market

    21.1. Eastern Europe Open-Angle Glaucoma (OAG) Market Overview

    21.2. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Open-Angle Glaucoma (OAG) Market

    22.1. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Open-Angle Glaucoma (OAG) Market

    23.1. North America Open-Angle Glaucoma (OAG) Market Overview

    23.2. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Open-Angle Glaucoma (OAG) Market

    24.1. USA Open-Angle Glaucoma (OAG) Market Overview

    24.2. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Open-Angle Glaucoma (OAG) Market

    25.1. Canada Open-Angle Glaucoma (OAG) Market Overview

    25.2. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Open-Angle Glaucoma (OAG) Market

    26.1. South America Open-Angle Glaucoma (OAG) Market Overview

    26.2. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Open-Angle Glaucoma (OAG) Market

    27.1. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Open-Angle Glaucoma (OAG) Market

    28.1. Middle East Open-Angle Glaucoma (OAG) Market Overview

    28.2. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Open-Angle Glaucoma (OAG) Market

    29.1. Africa Open-Angle Glaucoma (OAG) Market Overview

    29.2. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Open-Angle Glaucoma (OAG) Market Competitive Landscape And Company Profiles

    30.1. Open-Angle Glaucoma (OAG) Market Competitive Landscape

    30.2. Open-Angle Glaucoma (OAG) Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

    31. Open-Angle Glaucoma (OAG) Market Other Major And Innovative Companies

    31.1. Teva Pharmaceutical Industries Ltd.

    31.2. Boston Scientific

    31.3. Alcon Inc.

    31.4. Bausch Health Companies Inc.

    31.5. Hoya Corporation

    31.6. Sun Pharmaceutical Industries Ltd.

    31.7. Santen Pharmaceuticals

    31.8. Mallinckrodt Pharmaceuticals

    31.9. Théa Pharma

    31.10. Glaukos Corporation

    31.11. Quantel Medical

    31.12. EyePoint Pharmaceuticals Inc.

    31.13. iSTAR Medical

    31.14. Nicox Ophthalmics

    31.15. Visus Therapeutics

    32. Global Open-Angle Glaucoma (OAG) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Open-Angle Glaucoma (OAG) Market

    34. Recent Developments In The Open-Angle Glaucoma (OAG) Market

    35. Open-Angle Glaucoma (OAG) Market High Potential Countries, Segments and Strategies

    35.1 Open-Angle Glaucoma (OAG) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Open-Angle Glaucoma (OAG) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Open-Angle Glaucoma (OAG) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Merck & Co. Inc. Financial Performance
  • Table 80: AbbVie Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Amgen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Open-Angle Glaucoma (OAG) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Open Angle Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Angle Closure Glaucoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Open-Angle Glaucoma (OAG) Market, Sub-Segmentation Of Other Disease Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Open-Angle Glaucoma (OAG) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Open-Angle Glaucoma (OAG) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Open-Angle Glaucoma (OAG) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Merck & Co. Inc. Financial Performance
  • Figure 80: AbbVie Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Amgen Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Open-Angle Glaucoma (OAG) market?

Open-angle glaucoma (OAG) is a chronic, progressive eye condition characterized by the gradual clogging of the drainage canals in the eye, leading to increased intraocular pressure that damages the optic nerve, often without noticeable symptoms until significant vision loss occurs. Its treatment aims to lower intraocular pressure, thereby preventing optic nerve damage and preserving vision through medications, laser procedures, or surgical interventions. For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here

How will the Open-Angle Glaucoma (OAG) market drivers and restraints affect the market dynamics? What forces will shape the Open-Angle Glaucoma (OAG) industry going forward?

The Open-Angle Glaucoma (OAG) market major growth driver - Growing Awareness Of Eye Illnesses Drives Growth In The Market. For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here

What is the forecast market size or the forecast market value of the Open-Angle Glaucoma (OAG) market?

The Open-Angle Glaucoma (OAG) market size has grown strongly in recent years. The open-angle glaucoma (OAG) market size has grown strongly in recent years. It will grow from $6.13 billion in 2024 to $6.55 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increasing prevalence of glaucoma among aging populations, growing awareness about early detection of eye diseases, rising healthcare expenditure, government initiatives for vision care programs, and expansion of ophthalmology practices globally. The open-angle glaucoma (OAG) market size is expected to see strong growth in the next few years. It will grow to $8.42 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increasing demand for combination therapies, rising focus on personalized medicine, improved reimbursement policies for glaucoma treatments, increasing prevalence of lifestyle-induced ocular conditions, and rising demand for non-invasive diagnostic methods. Major trends in the forecast period include growing adoption of AI in glaucoma diagnostics, a shift toward outpatient glaucoma surgical procedures, increasing use of sustained-release glaucoma implants, rising integration of wearable technology for monitoring intraocular pressure, and heightened focus on sustainability in medical device manufacturing. For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here

How is the Open-Angle Glaucoma (OAG) market segmented?

The open-angle glaucoma (OAG) market covered in this report is segmented –
1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type
2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy Subsegments:
1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma
2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma
3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma For further insights on the Open-Angle Glaucoma (OAG) market,
request a sample here

Which region has the largest share of the Open-Angle Glaucoma (OAG) market? What are the other regions covered in the report?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here.

Who are the major players in the Open-Angle Glaucoma (OAG) market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals . For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here.

What are the key trends in the Open-Angle Glaucoma (OAG) market?

Major trends in the Open-Angle Glaucoma (OAG) market include Innovative Devices Revolutionize Glaucoma Treatment With Minimally Invasive Solutions. For further insights on the Open-Angle Glaucoma (OAG) market, request a sample here.

What are the major opportunities in the Open-Angle Glaucoma (OAG) market? What are the strategies for the Open-Angle Glaucoma (OAG) market?

For detailed insights on the major opportunities and strategies in the Open-Angle Glaucoma (OAG) market, request a sample here.

How does the Open-Angle Glaucoma (OAG) market relate to the overall economy and other similar markets?

For detailed insights on Open-Angle Glaucoma (OAG)'s relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Open-Angle Glaucoma (OAG) industry?

For detailed insights on the mergers and acquisitions in the Open-Angle Glaucoma (OAG) industry, request a sample here.

What are the key dynamics influencing the Open-Angle Glaucoma (OAG) market growth? SWOT analysis of the Open-Angle Glaucoma (OAG) market.

For detailed insights on the key dynamics influencing the Open-Angle Glaucoma (OAG) market growth and SWOT analysis of the Open-Angle Glaucoma (OAG) industry, request a sample here.